img

Global Neurosurgery Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Neurosurgery Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Neurosurgery is the surgery of the nervous system. Most of the time people think that neurosurgery is nothing but the surgery of the brain but looking deeply it is much more than that. Neurosurgery is the medical specialty that is concerned with the diagnosis of an injury or the disease that is concerned with the brain. Depending upon the patients and injury or disease doctor may choose to go for non-surgical procedures as well. There are several drugs present in the market which helps in getting relief from post neurosurgical seizures and pain. Which requires the doctor’s approval.
Neurosurgery Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neurosurgery Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neurosurgery Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
AstraZeneca
Biogen
Jhonson & Jhonson
ABBVIE
Takeda Pharmaceuticals
UCB
IPSEN
Standigm
BlueStar Genomic
Tonix Pharmaceuticals
BlackThorn Therapeutics
Quentrix
Wren Pharmaceuticals
Segment by Type
Tablets
Solution
Capsules
Others

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Neurosurgery Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Neurosurgery Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Neurosurgery Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Neurosurgery Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Neurosurgery Drug introduction, etc. Neurosurgery Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Neurosurgery Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Neurosurgery Drug Market Overview
1.1 Neurosurgery Drug Product Overview
1.2 Neurosurgery Drug Market Segment by Type
1.2.1 Tablets
1.2.2 Solution
1.2.3 Capsules
1.2.4 Others
1.3 Global Neurosurgery Drug Market Size by Type
1.3.1 Global Neurosurgery Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Neurosurgery Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Neurosurgery Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Neurosurgery Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Neurosurgery Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Neurosurgery Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Neurosurgery Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Neurosurgery Drug Sales Breakdown by Type (2018-2024)
2 Global Neurosurgery Drug Market Competition by Company
2.1 Global Top Players by Neurosurgery Drug Sales (2018-2024)
2.2 Global Top Players by Neurosurgery Drug Revenue (2018-2024)
2.3 Global Top Players by Neurosurgery Drug Price (2018-2024)
2.4 Global Top Manufacturers Neurosurgery Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Neurosurgery Drug Market Competitive Situation and Trends
2.5.1 Neurosurgery Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Neurosurgery Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurosurgery Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Neurosurgery Drug Market
2.8 Key Manufacturers Neurosurgery Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Neurosurgery Drug Status and Outlook by Region
3.1 Global Neurosurgery Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Neurosurgery Drug Historic Market Size by Region
3.2.1 Global Neurosurgery Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Neurosurgery Drug Sales in Value by Region (2018-2024)
3.2.3 Global Neurosurgery Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Neurosurgery Drug Forecasted Market Size by Region
3.3.1 Global Neurosurgery Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Neurosurgery Drug Sales in Value by Region (2024-2029)
3.3.3 Global Neurosurgery Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Neurosurgery Drug by Application
4.1 Neurosurgery Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Neurosurgery Drug Market Size by Application
4.2.1 Global Neurosurgery Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Neurosurgery Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Neurosurgery Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Neurosurgery Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Neurosurgery Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Neurosurgery Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Neurosurgery Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Neurosurgery Drug Sales Breakdown by Application (2018-2024)
5 North America Neurosurgery Drug by Country
5.1 North America Neurosurgery Drug Historic Market Size by Country
5.1.1 North America Neurosurgery Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Neurosurgery Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Neurosurgery Drug Sales in Value by Country (2018-2024)
5.2 North America Neurosurgery Drug Forecasted Market Size by Country
5.2.1 North America Neurosurgery Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Neurosurgery Drug Sales in Value by Country (2024-2029)
6 Europe Neurosurgery Drug by Country
6.1 Europe Neurosurgery Drug Historic Market Size by Country
6.1.1 Europe Neurosurgery Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Neurosurgery Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Neurosurgery Drug Sales in Value by Country (2018-2024)
6.2 Europe Neurosurgery Drug Forecasted Market Size by Country
6.2.1 Europe Neurosurgery Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Neurosurgery Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Neurosurgery Drug by Region
7.1 Asia-Pacific Neurosurgery Drug Historic Market Size by Region
7.1.1 Asia-Pacific Neurosurgery Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Neurosurgery Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Neurosurgery Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Neurosurgery Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Neurosurgery Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Neurosurgery Drug Sales in Value by Region (2024-2029)
8 Latin America Neurosurgery Drug by Country
8.1 Latin America Neurosurgery Drug Historic Market Size by Country
8.1.1 Latin America Neurosurgery Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Neurosurgery Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Neurosurgery Drug Sales in Value by Country (2018-2024)
8.2 Latin America Neurosurgery Drug Forecasted Market Size by Country
8.2.1 Latin America Neurosurgery Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Neurosurgery Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Neurosurgery Drug by Country
9.1 Middle East and Africa Neurosurgery Drug Historic Market Size by Country
9.1.1 Middle East and Africa Neurosurgery Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Neurosurgery Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Neurosurgery Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Neurosurgery Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Neurosurgery Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Neurosurgery Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Neurosurgery Drug Products Offered
10.1.5 Pfizer Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AstraZeneca Neurosurgery Drug Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Biogen
10.3.1 Biogen Company Information
10.3.2 Biogen Introduction and Business Overview
10.3.3 Biogen Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Biogen Neurosurgery Drug Products Offered
10.3.5 Biogen Recent Development
10.4 Jhonson & Jhonson
10.4.1 Jhonson & Jhonson Company Information
10.4.2 Jhonson & Jhonson Introduction and Business Overview
10.4.3 Jhonson & Jhonson Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Jhonson & Jhonson Neurosurgery Drug Products Offered
10.4.5 Jhonson & Jhonson Recent Development
10.5 ABBVIE
10.5.1 ABBVIE Company Information
10.5.2 ABBVIE Introduction and Business Overview
10.5.3 ABBVIE Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 ABBVIE Neurosurgery Drug Products Offered
10.5.5 ABBVIE Recent Development
10.6 Takeda Pharmaceuticals
10.6.1 Takeda Pharmaceuticals Company Information
10.6.2 Takeda Pharmaceuticals Introduction and Business Overview
10.6.3 Takeda Pharmaceuticals Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Takeda Pharmaceuticals Neurosurgery Drug Products Offered
10.6.5 Takeda Pharmaceuticals Recent Development
10.7 UCB
10.7.1 UCB Company Information
10.7.2 UCB Introduction and Business Overview
10.7.3 UCB Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 UCB Neurosurgery Drug Products Offered
10.7.5 UCB Recent Development
10.8 IPSEN
10.8.1 IPSEN Company Information
10.8.2 IPSEN Introduction and Business Overview
10.8.3 IPSEN Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 IPSEN Neurosurgery Drug Products Offered
10.8.5 IPSEN Recent Development
10.9 Standigm
10.9.1 Standigm Company Information
10.9.2 Standigm Introduction and Business Overview
10.9.3 Standigm Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Standigm Neurosurgery Drug Products Offered
10.9.5 Standigm Recent Development
10.10 BlueStar Genomic
10.10.1 BlueStar Genomic Company Information
10.10.2 BlueStar Genomic Introduction and Business Overview
10.10.3 BlueStar Genomic Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 BlueStar Genomic Neurosurgery Drug Products Offered
10.10.5 BlueStar Genomic Recent Development
10.11 Tonix Pharmaceuticals
10.11.1 Tonix Pharmaceuticals Company Information
10.11.2 Tonix Pharmaceuticals Introduction and Business Overview
10.11.3 Tonix Pharmaceuticals Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Tonix Pharmaceuticals Neurosurgery Drug Products Offered
10.11.5 Tonix Pharmaceuticals Recent Development
10.12 BlackThorn Therapeutics
10.12.1 BlackThorn Therapeutics Company Information
10.12.2 BlackThorn Therapeutics Introduction and Business Overview
10.12.3 BlackThorn Therapeutics Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 BlackThorn Therapeutics Neurosurgery Drug Products Offered
10.12.5 BlackThorn Therapeutics Recent Development
10.13 Quentrix
10.13.1 Quentrix Company Information
10.13.2 Quentrix Introduction and Business Overview
10.13.3 Quentrix Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Quentrix Neurosurgery Drug Products Offered
10.13.5 Quentrix Recent Development
10.14 Wren Pharmaceuticals
10.14.1 Wren Pharmaceuticals Company Information
10.14.2 Wren Pharmaceuticals Introduction and Business Overview
10.14.3 Wren Pharmaceuticals Neurosurgery Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Wren Pharmaceuticals Neurosurgery Drug Products Offered
10.14.5 Wren Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Neurosurgery Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Neurosurgery Drug Industrial Chain Analysis
11.4 Neurosurgery Drug Market Dynamics
11.4.1 Neurosurgery Drug Industry Trends
11.4.2 Neurosurgery Drug Market Drivers
11.4.3 Neurosurgery Drug Market Challenges
11.4.4 Neurosurgery Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Neurosurgery Drug Distributors
12.3 Neurosurgery Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tablets
Table 2. Major Company of Solution
Table 3. Major Company of Capsules
Table 4. Major Company of Others
Table 5. Global Neurosurgery Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Neurosurgery Drug Sales by Type (2018-2024) & (K Units)
Table 7. Global Neurosurgery Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Neurosurgery Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Neurosurgery Drug Market Share in Value by Type (2018-2024)
Table 10. Global Neurosurgery Drug Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Neurosurgery Drug Sales by Type (2024-2029) & (K Units)
Table 12. Global Neurosurgery Drug Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Neurosurgery Drug Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Neurosurgery Drug Sales Market Share in Value by Type (2024-2029)
Table 15. Global Neurosurgery Drug Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Neurosurgery Drug Sales by Type (2018-2024) & (K Units)
Table 17. North America Neurosurgery Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Neurosurgery Drug Sales (K Units) by Type (2018-2024)
Table 19. Europe Neurosurgery Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Neurosurgery Drug Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Neurosurgery Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Neurosurgery Drug Sales (K Units) by Type (2018-2024)
Table 23. Latin America Neurosurgery Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Neurosurgery Drug Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Neurosurgery Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Neurosurgery Drug Sales by Company (2018-2024) & (K Units)
Table 27. Global Neurosurgery Drug Sales Share by Company (2018-2024)
Table 28. Global Neurosurgery Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Neurosurgery Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Neurosurgery Drug Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Neurosurgery Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Neurosurgery Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurosurgery Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Neurosurgery Drug Market
Table 35. Key Manufacturers Neurosurgery Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Neurosurgery Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Neurosurgery Drug Sales by Region (2018-2024) & (K Units)
Table 39. Global Neurosurgery Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Neurosurgery Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Neurosurgery Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Neurosurgery Drug Sales by Region (2024-2029) & (K Units)
Table 44. Global Neurosurgery Drug Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Neurosurgery Drug Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Neurosurgery Drug Sales Market Share in Value by Region (2024-2029)
Table 47. Global Neurosurgery Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Neurosurgery Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Neurosurgery Drug Sales by Application (2018-2024) & (K Units)
Table 50. Global Neurosurgery Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Neurosurgery Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Neurosurgery Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Neurosurgery Drug Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Neurosurgery Drug Sales by Application (2024-2029) & (K Units)
Table 55. Global Neurosurgery Drug Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Neurosurgery Drug Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Neurosurgery Drug Sales Market Share in Value by Application (2024-2029)
Table 58. Global Neurosurgery Drug Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Neurosurgery Drug Sales by Application (2018-2024) (K Units)
Table 60. North America Neurosurgery Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Neurosurgery Drug Sales by Application (2018-2024) (K Units)
Table 62. Europe Neurosurgery Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Neurosurgery Drug Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Neurosurgery Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Neurosurgery Drug Sales by Application (2018-2024) (K Units)
Table 66. Latin America Neurosurgery Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Neurosurgery Drug Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Neurosurgery Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Neurosurgery Drug Sales by Country (2018-2024) & (K Units)
Table 70. North America Neurosurgery Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Neurosurgery Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Neurosurgery Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Neurosurgery Drug Sales by Country (2024-2029) & (K Units)
Table 74. North America Neurosurgery Drug Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Neurosurgery Drug Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Neurosurgery Drug Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Neurosurgery Drug Sales by Country (2018-2024) & (K Units)
Table 78. Europe Neurosurgery Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Neurosurgery Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Neurosurgery Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Neurosurgery Drug Sales by Country (2024-2029) & (K Units)
Table 82. Europe Neurosurgery Drug Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Neurosurgery Drug Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Neurosurgery Drug Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Neurosurgery Drug Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Neurosurgery Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Neurosurgery Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Neurosurgery Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Neurosurgery Drug Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Neurosurgery Drug Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Neurosurgery Drug Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Neurosurgery Drug Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Neurosurgery Drug Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Neurosurgery Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Neurosurgery Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Neurosurgery Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Neurosurgery Drug Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Neurosurgery Drug Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Neurosurgery Drug Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Neurosurgery Drug Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Neurosurgery Drug Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Neurosurgery Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Neurosurgery Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Neurosurgery Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Neurosurgery Drug Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Neurosurgery Drug Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Neurosurgery Drug Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Neurosurgery Drug Sales Market Share in Value by Country (2024-2029)
Table 109. Pfizer Company Information
Table 110. Pfizer Introduction and Business Overview
Table 111. Pfizer Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Pfizer Neurosurgery Drug Product
Table 113. Pfizer Recent Development
Table 114. AstraZeneca Company Information
Table 115. AstraZeneca Introduction and Business Overview
Table 116. AstraZeneca Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. AstraZeneca Neurosurgery Drug Product
Table 118. AstraZeneca Recent Development
Table 119. Biogen Company Information
Table 120. Biogen Introduction and Business Overview
Table 121. Biogen Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Biogen Neurosurgery Drug Product
Table 123. Biogen Recent Development
Table 124. Jhonson & Jhonson Company Information
Table 125. Jhonson & Jhonson Introduction and Business Overview
Table 126. Jhonson & Jhonson Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Jhonson & Jhonson Neurosurgery Drug Product
Table 128. Jhonson & Jhonson Recent Development
Table 129. ABBVIE Company Information
Table 130. ABBVIE Introduction and Business Overview
Table 131. ABBVIE Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. ABBVIE Neurosurgery Drug Product
Table 133. ABBVIE Recent Development
Table 134. Takeda Pharmaceuticals Company Information
Table 135. Takeda Pharmaceuticals Introduction and Business Overview
Table 136. Takeda Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Takeda Pharmaceuticals Neurosurgery Drug Product
Table 138. Takeda Pharmaceuticals Recent Development
Table 139. UCB Company Information
Table 140. UCB Introduction and Business Overview
Table 141. UCB Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. UCB Neurosurgery Drug Product
Table 143. UCB Recent Development
Table 144. IPSEN Company Information
Table 145. IPSEN Introduction and Business Overview
Table 146. IPSEN Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. IPSEN Neurosurgery Drug Product
Table 148. IPSEN Recent Development
Table 149. Standigm Company Information
Table 150. Standigm Introduction and Business Overview
Table 151. Standigm Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Standigm Neurosurgery Drug Product
Table 153. Standigm Recent Development
Table 154. BlueStar Genomic Company Information
Table 155. BlueStar Genomic Introduction and Business Overview
Table 156. BlueStar Genomic Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. BlueStar Genomic Neurosurgery Drug Product
Table 158. BlueStar Genomic Recent Development
Table 159. Tonix Pharmaceuticals Company Information
Table 160. Tonix Pharmaceuticals Introduction and Business Overview
Table 161. Tonix Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Tonix Pharmaceuticals Neurosurgery Drug Product
Table 163. Tonix Pharmaceuticals Recent Development
Table 164. BlackThorn Therapeutics Company Information
Table 165. BlackThorn Therapeutics Introduction and Business Overview
Table 166. BlackThorn Therapeutics Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. BlackThorn Therapeutics Neurosurgery Drug Product
Table 168. BlackThorn Therapeutics Recent Development
Table 169. Quentrix Company Information
Table 170. Quentrix Introduction and Business Overview
Table 171. Quentrix Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Quentrix Neurosurgery Drug Product
Table 173. Quentrix Recent Development
Table 174. Wren Pharmaceuticals Company Information
Table 175. Wren Pharmaceuticals Introduction and Business Overview
Table 176. Wren Pharmaceuticals Neurosurgery Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Wren Pharmaceuticals Neurosurgery Drug Product
Table 178. Wren Pharmaceuticals Recent Development
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Neurosurgery Drug Market Trends
Table 182. Neurosurgery Drug Market Drivers
Table 183. Neurosurgery Drug Market Challenges
Table 184. Neurosurgery Drug Market Restraints
Table 185. Neurosurgery Drug Distributors List
Table 186. Neurosurgery Drug Downstream Customers
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurosurgery Drug Product Picture
Figure 2. Global Neurosurgery Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Neurosurgery Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Neurosurgery Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Tablets
Figure 6. Global Tablets Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Solution
Figure 8. Global Solution Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Capsules
Figure 10. Global Capsules Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Neurosurgery Drug Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Neurosurgery Drug Sales Market Share by Type in 2022 & 2029
Figure 15. North America Neurosurgery Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Neurosurgery Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Neurosurgery Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Neurosurgery Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Neurosurgery Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Neurosurgery Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Neurosurgery Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Neurosurgery Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Neurosurgery Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Neurosurgery Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Neurosurgery Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Neurosurgery Drug Revenue in 2022
Figure 27. Neurosurgery Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Clinic
Figure 31. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Neurosurgery Drug Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Neurosurgery Drug Sales Market Share by Application in 2022 & 2029
Figure 36. North America Neurosurgery Drug Sales Market Share in Volume by Application in 2022
Figure 37. North America Neurosurgery Drug Sales Market Share in Value by Application in 2022
Figure 38. Europe Neurosurgery Drug Sales Market Share in Volume by Application in 2022
Figure 39. Europe Neurosurgery Drug Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Neurosurgery Drug Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Neurosurgery Drug Sales Market Share in Value by Application in 2022
Figure 42. Latin America Neurosurgery Drug Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Neurosurgery Drug Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Neurosurgery Drug Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Neurosurgery Drug Manufacturing Cost Structure
Figure 47. Neurosurgery Drug Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries